Amanda Elizabeth Inn Proudfoot
#154,464
Most Influential Person Now
Amanda Elizabeth Inn Proudfoot's AcademicInfluence.com Rankings
Amanda Elizabeth Inn Proudfootbiology Degrees
Biology
#11805
World Rank
#15229
Historical Rank
Molecular Biology
#1858
World Rank
#1887
Historical Rank
Biochemistry
#1973
World Rank
#2114
Historical Rank

Download Badge
Chemistry Biology
Amanda Elizabeth Inn Proudfoot's Degrees
- PhD Biochemistry Stanford University
- Bachelors Chemistry University of California, Berkeley
Why Is Amanda Elizabeth Inn Proudfoot Influential?
(Suggest an Edit or Addition)Amanda Elizabeth Inn Proudfoot's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines (2003) (813)
- Chemokine receptors: multifaceted therapeutic targets (2002) (723)
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice (2008) (647)
- International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors (2014) (629)
- Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. (1997) (628)
- RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium (2001) (603)
- The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness (1998) (594)
- Lymph-Borne Chemokines and Other Low Molecular Weight Molecules Reach High Endothelial Venules via Specialized Conduits While a Functional Barrier Limits Access to the Lymphocyte Microenvironments in Lymph Node Cortex (2000) (589)
- Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. (1999) (574)
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin (2001) (550)
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 (2012) (531)
- RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis (1997) (521)
- Glycosaminoglycans mediate cell surface oligomerization of chemokines. (1997) (518)
- Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. (2005) (516)
- Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity (1998) (440)
- Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice (2004) (381)
- Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. (2005) (352)
- Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells (1997) (307)
- Overcoming hurdles in developing successful drugs targeting chemokine receptors (2011) (306)
- HIV-1 Tat protein mimicry of chemokines. (1998) (304)
- A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock (2000) (295)
- Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice1 (2001) (281)
- Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. (1999) (278)
- Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA from a Human Basophilic Cell Line (*) (1995) (277)
- A chemokine receptor antagonist inhibits experimental breast tumor growth. (2003) (275)
- Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment (1999) (268)
- Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo (1997) (265)
- Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. (2000) (262)
- Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. (2005) (259)
- The BBXB Motif of RANTES Is the Principal Site for Heparin Binding and Controls Receptor Selectivity* (2001) (247)
- Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. (1997) (245)
- A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 (1993) (229)
- Granzyme A is an interleukin 1 beta-converting enzyme (1995) (223)
- Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. (1999) (221)
- Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. (2010) (215)
- Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1 (2004) (207)
- Differential Effects of CC Chemokines on CC Chemokine Receptor 5 (CCR5) Phosphorylation and Identification of Phosphorylation Sites on the CCR5 Carboxyl Terminus* (1999) (207)
- Endocytosis and Recycling of the HIV Coreceptor Ccr5 (2000) (197)
- Ticks produce highly selective chemokine binding proteins with antiinflammatory activity (2008) (194)
- Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. (1997) (186)
- Identification of a glycosaminoglycan binding surface on human interleukin-8. (1998) (183)
- Chemokine blockers--therapeutics in the making? (2006) (177)
- The Core Domain of Chemokines Binds CCR5 Extracellular Domains while Their Amino Terminus Interacts with the Transmembrane Helix Bundle* (2003) (168)
- Characterization of Sequence Determinants within the Carboxyl-terminal Domain of Chemokine Receptor CCR5 That Regulate Signaling and Receptor Internalization* (2001) (166)
- Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors* (1999) (166)
- The biological relevance of chemokine-proteoglycan interactions. (2006) (164)
- Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System (2004) (164)
- Selectivity and antagonism of chemokine receptors (1996) (159)
- The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat1 (2001) (156)
- TSG-6 Inhibits Neutrophil Migration via Direct Interaction with the Chemokine CXCL8 (2014) (152)
- Neutrophil-Derived CCL3 Is Essential for the Rapid Recruitment of Dendritic Cells to the Site of Leishmania major Inoculation in Resistant Mice (2010) (149)
- Chronic expression of monocyte chemoattractant protein‐1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice (2005) (145)
- Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion (1999) (140)
- Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis (1999) (132)
- Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands (2000) (130)
- The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 (1997) (130)
- C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 (2000) (129)
- Amelioration of rat adjuvant-induced arthritis by Met-RANTES. (2005) (129)
- Definition, function and pathophysiological significance of chemokine receptors. (1998) (127)
- A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice (2008) (126)
- RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. (2003) (121)
- RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells* (2001) (120)
- The CC-Chemokine RANTES Increases the Attachment of Human Immunodeficiency Virus Type 1 to Target Cells via Glycosaminoglycans and Also Activates a Signal Transduction Pathway That Enhances Viral Infectivity (1999) (117)
- Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus* (2007) (116)
- Anti-chemokine small molecule drugs: a promising future? (2010) (115)
- Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. (2003) (112)
- Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. (2003) (110)
- Chemokine inhibition--why, when, where, which and how? (2004) (107)
- Early application of Met-RANTES ameliorates chronic allograft nephropathy. (2002) (106)
- Selective recruitment of Th2‐type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein‐II (2001) (105)
- Kinetics of Chemokine–Glycosaminoglycan Interactions Control Neutrophil Migration into the Airspaces of the Lungs (2010) (105)
- Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis1 (2008) (102)
- The three-dimensional solution structure of RANTES. (1995) (99)
- Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. (2010) (97)
- The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. (2004) (96)
- Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection (2004) (93)
- Strategies for chemokine antagonists as therapeutics. (2003) (91)
- Multi-faceted strategies to combat disease by interference with the chemokine system. (2005) (91)
- CCL3/MIP‐1α is pro‐inflammatory in murine T cell‐mediated hepatitis by recruiting CCR1‐expressing CD4+ T cells to the liver (2004) (91)
- Receptor-mediated Endocytosis of CC-chemokines* (1997) (90)
- The strategy of blocking the chemokine system to combat disease (2000) (90)
- HMGB 1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL 12 and signaling via CXCR 4 (2012) (89)
- Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System (2017) (87)
- Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis. (2009) (87)
- The X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution (1996) (85)
- Differential Activation of CC Chemokine Receptors by AOP-RANTES* (2000) (85)
- CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. (2007) (84)
- Purification, cDNA cloning and heterologous expression of human phosphomannose isomerase. (1994) (83)
- Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES (2002) (81)
- Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. (1996) (80)
- Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine. (1995) (77)
- An engineered monomer of CCL2 has anti‐inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo (2008) (77)
- Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro (2006) (76)
- Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice (2010) (74)
- CCL5-CCR5-mediated Apoptosis in T Cells (2006) (71)
- Close Association of the First and Fourth Extracellular Domains of the Duffy Antigen/Receptor for Chemokines by a Disulfide Bond Is Required for Ligand Binding* (1997) (69)
- Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3 (2003) (68)
- Mutation of Leu25 and Val27 Introduces CC Chemokine Activity into Interleukin-8 (*) (1995) (68)
- PMI40, an intron-containing gene required for early steps in yeast mannosylation (1992) (68)
- Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans* (2010) (67)
- Leukocyte Adhesion: Reconceptualizing Chemokine Presentation by Glycosaminoglycans. (2019) (63)
- Chemokine receptors--future therapeutic targets for HIV? (1999) (62)
- Functional role of CCL5/RANTES for HCC progression during chronic liver disease. (2017) (60)
- The effect of CCL3 and CCR1 in bone remodeling induced by mechanical loading during orthodontic tooth movement in mice. (2013) (57)
- Targeting chemokines: Pathogens can, why can't we? (2015) (56)
- Current status of chemokine receptor inhibitors in development. (2012) (55)
- Treatment with Evasin-3 Reduces Atherosclerotic Vulnerability for Ischemic Stroke, but Not Brain Injury in Mice (2013) (55)
- Angiotensin II-Induced Mononuclear Leukocyte Interactions with Arteriolar and Venular Endothelium Are Mediated by the Release of Different CC Chemokines1 (2006) (55)
- Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation (*) (1995) (54)
- Modulation of Chemokine Responses: Synergy and Cooperativity (2016) (53)
- Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c. (1988) (52)
- The chemokine system: novel broad-spectrum therapeutic targets. (2001) (52)
- IL-3 Induces Down-Regulation of CCR3 Protein and mRNA in Human Eosinophils1 (2001) (52)
- Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. (2009) (50)
- Chemokine receptors - the new frontier for AIDS research. (1996) (50)
- Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis. (2011) (49)
- The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH* (2015) (49)
- Chapter 4. Interactions of chemokines with glycosaminoglycans. (2009) (48)
- Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice (2013) (48)
- Chemokines as targets for therapy. (2011) (47)
- Chemokine receptors and their role in leukocyte activation. (1999) (45)
- An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils (1997) (45)
- The CCL3/Macrophage Inflammatory Protein-1α–Binding Protein Evasin-1 Protects from Graft-versus-Host Disease but Does Not Modify Graft-versus-Leukemia in Mice (2010) (45)
- Glycosaminoglycan analogs as a novel anti-inflammatory strategy (2012) (44)
- Interaction of the CC-Chemokine RANTES with Glycosaminoglycans Activates a p44/p42 Mitogen-Activated Protein Kinase-Dependent Signaling Pathway and Enhances Human Immunodeficiency Virus Type 1 Infectivity (2002) (44)
- Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. (2002) (44)
- Tissue-Specific Mechanisms Control the Retention of IL-8 in Lungs and Skin1 (2002) (44)
- Treatment with Evasin‐3 abrogates neutrophil‐mediated inflammation in mouse acute pancreatitis (2014) (43)
- Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3 (2009) (43)
- Substitutions engineered by chemical synthesis at three conserved sites in mitochondrial cytochrome c. Thermodynamic and functional consequences. (1989) (42)
- Recombinant guinea pig and human RANTES activate macrophages but not eosinophils in the guinea pig. (1997) (42)
- The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. (2005) (41)
- The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions (1999) (39)
- Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines. (1995) (39)
- A chimeric MIP‐1α/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors (2001) (39)
- Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice1 (2001) (39)
- Purification and characterization of fungal and mammalian phosphomannose isomerases (1994) (38)
- In vitro and in vivo studies with purified recombinant human interleukin 5. (1990) (38)
- Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. (1990) (37)
- The use of chemokine antagonists in EAE models (2008) (36)
- Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. (1993) (36)
- Chemokines bind to sulfatides as revealed by surface plasmon resonance. (2005) (36)
- Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models (2013) (35)
- The cytochrome c oxidase-cytochrome c complex: spectroscopic analysis of conformational changes in the protein-protein interaction domain. (1989) (32)
- Protein therapeutics – lessons learned and a view of the future (2006) (31)
- Phosphomannose isomerase from Saccharomyces cerevisiae contains two inhibitory metal ion binding sites. (1993) (31)
- Purification of recombinant chemokines from E. coli. (2000) (31)
- On the relationship between oxidation-reduction potential and biological activity in cytochrome c analogues. Results from four novel two-fragment complexes. (1987) (30)
- CCR1 and CCR5 chemokine receptors are involved in fever induced by LPS (E. coli) and RANTES in rats (2007) (29)
- The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance (2005) (28)
- The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans (2013) (28)
- Cloning and Characterization of a Novel Murine Macrophage Inflammatory Protein-1α Receptor* (1996) (28)
- Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks (2016) (27)
- Structure and Bioactivity of Recombinant Human CTAP-III and NAP-2 (1997) (26)
- Antagonism of the chemokine Ccl 5 ameliorates experimental liver fibrosis in mice (2010) (26)
- Chemokine Cooperativity Is Caused by Competitive Glycosaminoglycan Binding (2014) (26)
- CCL18 Exhibits a Regulatory Role through Inhibition of Receptor and Glycosaminoglycan Binding (2013) (26)
- Met-RANTES Inhibition of Mucosal Perfusion Failure in Acute Intestinal Transplant Rejection – Role of Endothelial Cell-Leukocyte Interaction (2002) (26)
- Chemokines and Glycosaminoglycans (2015) (25)
- Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss (2009) (25)
- A fluorescent interleukin-8 receptor probe produced by targetted labelling at the amino terminus. (1995) (25)
- In vivo and in vitro folding of a recombinant metalloenzyme, phosphomannose isomerase. (1996) (24)
- Multiple T cell antigenic determinants identified within a limited region of the horse cytochrome c molecule (1987) (24)
- Selenomethionine labelling of phosphomannose isomerase changes its kinetic properties. (1995) (24)
- A Molecular Switch of Chemokine Receptor Selectivity (1996) (24)
- Relevance of CCL3/CCR5 axis in oral carcinogenesis. (2017) (23)
- Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display* (2014) (23)
- Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice (2001) (23)
- Is CCR2 the right chemokine receptor to target in rheumatoid arthritis? (2008) (21)
- Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines (2020) (21)
- Two Distinct Signalling Pathways Are Involved in the Control of the Biphasic junB Transcription Induced by Interleukin-6 in the B Cell Hybridoma 7TD1 (*) (1995) (20)
- Synthesis and evaluation of fluorescent chemokines labeled at the amino terminal. (1997) (20)
- Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. (2007) (20)
- Up-Regulation of CCR1 and CCR3 and Induction of Chemotaxis to CC Chemokines by IFN-g in Human (1999) (20)
- Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants. (1995) (19)
- Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1. (1999) (19)
- Purification, characterisation and crystallisation of selenomethionyl recombinant human interleukin-5 from Escherichia coli. (1993) (19)
- The basic residue cluster (55)KKWVR(59) in CCL5 is required for in vivo biologic function. (2009) (19)
- Detection and identification of plasma proteins that bind GlialCAM using ProteinChip™ Arrays, SELDI‐TOF MS, and nano‐LC MS/MS (2008) (18)
- Relevance of CCL3/CCR5 axis in oral carcinogenesis (2017) (18)
- Conformation-directed recombination of enzyme-activated peptide fragments: a simple and efficient means to protein engineering. Its use in the creation of cytochrome c analogues for structure-function studies. (1989) (18)
- Discovery of a novel series of CXCR3 antagonists. (2010) (18)
- The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. (1996) (17)
- Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition. (2001) (17)
- Identification of Cys-150 in the active site of phosphomannose isomerase from Candida albicans. (1993) (16)
- Quantitative detection of therapeutic proteins and their metabolites in serum using antibody-coupled ProteinChip Arrays and SELDI-TOF-MS. (2006) (16)
- Enzyme-assisted semisynthesis of polypeptide active esters and their use. (1988) (16)
- A knottin scaffold directs the CXC-chemokine–binding specificity of tick evasins (2019) (16)
- Interference with Oligomerization and Glycosaminoglycan Binding of the Chemokine CCL5 Improves Experimental Liver Injury (2012) (15)
- The chemokine family. Potential therapeutic targets from allergy to HIV infection. (1998) (15)
- Drug discovery targeting the chemokine system--where are we? (2009) (14)
- Identification of an Fe(III)-dihydroxyphenylalanine site in recombinant phosphomannose isomerase from Candida albicans. (1997) (14)
- Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets. (1994) (12)
- A new non-covalent complex of semisynthetically modified tryptic fragments of cytochrome c. (1986) (12)
- The crystal structure of met-rantes: comparison with native rantes and aop-rantes (2000) (12)
- Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation. (2002) (12)
- Inhibition of phosphomannose isomerase by mercury ions. (1994) (11)
- Cloning and characterization of a novel murine macrophage inflammatory protein-1 alpha receptor. (1996) (11)
- Cellular Assays of Chemokine Receptor Activation (2001) (10)
- The Molecular Basis of Selectivity Between CC and CXC Chemokines: The Possibility of Chemokine Antagonists as Anti‐inflammatory Agents (1996) (10)
- Properties of 7ND-CCL2 are modulated upon fusion to Fc. (2012) (10)
- Semisynthesis of cytochrome c analogues. The effect of modifying the conserved residues 38 and 39. (1987) (9)
- Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils. (2001) (8)
- Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase. (1994) (8)
- Human interleukin-6: detection of 10 attomoles by colorimetric sandwich ELISA using immunopurified polyclonal anti-IL-6 antibodies. (1993) (8)
- Strategies to interfere with the chemokine network in disease. (1999) (7)
- Mice Chemokine Receptors CCR 2 and CCR 5 in Expression and Characterization of the Schlöndorff (2001) (7)
- Crystallization and preliminary X-ray diffraction studies of recombinant human interleukin-5. (1993) (7)
- Human interleukin-5 expressed in Escherichia coli has N-terminal modifications. (1992) (7)
- A case of spurious product formation during attempted resynthesis of proteins by reverse proteolysis. Some batches of 'pure' glycerol contain cross-linking agents. (1984) (6)
- Spatial Orientation of the α and βc Receptor Chain Binding Sites on Monomeric Human Interleukin-5 Constructs* (1997) (5)
- The complete primary structure of glycosylated porcine platelet factor 4. (1995) (5)
- Chemokine receptors and their antagonists in allergic lung disease (1999) (5)
- Aminooxypentane-RANTES Induces CCR3 Activation and Internalization of CCR3 from the Surface of Human Eosinophils (2001) (5)
- Viral macrophage inflammatory protein-II improves acute rejection in allogeneic rat kidney transplants (2010) (4)
- [Reduction of acute kidney transplantation rejection by the chemokine receptor antagonist Met-RANTES]. (1999) (4)
- Cloning and Characterization of a Novel Murine Macrophage Inflammatory Protein-1 (cid:97) Receptor* (1996) (4)
- Chemokine receptors--the next therapeutic target for HIV? (2001) (4)
- Chapter 2.2 – Chemokines (2002) (3)
- Crystallization and preliminary X-ray diffraction studies of human RANTES. (1994) (2)
- The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization (1996) (2)
- Chemokine receptors (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (2)
- Mutagenesis by Phage Display. (2016) (1)
- Targeting the Chemokine System (2003) (1)
- Antagonism of Chemokine Receptors in Preventing Infection by HIV (1999) (1)
- Editorial: Chemokines - beyond chemotaxis. (2018) (1)
- Crystal Structure of human RANTES mutant K45E (2004) (1)
- Pitfalls and Solutions for the Validation of Novel Drugs in Animal Models of Disease (2012) (1)
- Semisynthesis of a deletion mutant of cytochrome c by condensation of enzymatically activated fragments (1988) (1)
- Structural Aspects of Chemokines and Their Interactions with Receptors and Glycosaminoglycans (2011) (1)
- Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (1)
- A chemokine receptor antagonist reduces the incidence and severity of collagen induced arthritis in DBA/1 mice (1997) (1)
- ENZYME-ASSISTED SEMISYNTHESIS OF POLYPEPTIDE ACTIVE ESTERS FOR SUBSEQUENT SPONTANEOUS COUPLING (1987) (1)
- The selective pharmacologic inhibition of CXC chemokines is associated with an improvement of histological features of vulnerability in mouse atherosclerotic plaques (2013) (0)
- CS12-5. Which chemokine receptor should we target in Rheumatoid Arthritis (2011) (0)
- CHEMOKINES, CC | RANTES (CCL5) (2006) (0)
- Granzyme A Is an Interleukin 13-converting E n z y m e By (2003) (0)
- Chemokine receptor antagonist development. (2013) (0)
- Corrigendum to “CCR1 and CCR5 chemokine receptors are involved in fever induced by LPS (E. coli) and RANTES in rats” [Brain Res. 1161 (2007) 21–31] (2008) (0)
- Function of Inducing Stimulus Use of Alternative Chemokine Receptors as a Resting and Inflamed Airway Epithelium : Regulation of Dendritic Cell Recruitment into (2001) (0)
- Methods for the Recognition of GAG-Bound Chemokines. (2016) (0)
- 389 OLIGOMERIZATION AND GLYCOSAMINOGLYCAN BINDING OF THE CHEMOKINE CCL5 MEDIATES EXPERIMENTAL LIVER INJURY IN MICE (2012) (0)
- Isolation of a lipid-soluble histamine release factor from human platelets. (1994) (0)
- Both MIP-1α and RANTES and their receptors are expressed in murine vein grafts and aggravate vein graft remodeling (2008) (0)
- Using cc-chemokine CCL5 / RANTES mutant for treatment of liver diseases (2003) (0)
- CS6-2 What nature can teach us about chemokine function (2010) (0)
- Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft Rejection (2018) (0)
- Functional role of CCL5/RANTES for HCC progression during chronic liver disease: from humans to mice (2015) (0)
- Crystal Structure of human RANTES mutant 44-AANA-47 (2004) (0)
- in Human Neutrophils γ by IFN- Induction of Chemotaxis to CC Chemokines Up-Regulation of CCR1 and CCR3 and (2013) (0)
- Chemokines and their receptors: their biology and therapeutic relevance (2012) (0)
- Anti-Inflammatory Strategy Targeting the Oligomerization Creates a Novel Interference with Heparin Binding and (2017) (0)
- Cytochrome c̱ Semisynthesis Using Enzymic Resynthesis Techniques (1983) (0)
- Structure and activity of interleukin 5, a key mediator of asthmatic inflammation (1994) (0)
- Chemokines as drug targets (2007) (0)
- From Molecular Science to the Treatment of Allergy (1999) (0)
- The effect of the chemokine antagonist Met-RANTES on human eosinophils (1998) (0)
- Characterization of Chemokine Receptors (2001) (0)
- Retention of IL-8 in Lungs and Skin Tissue-Specific Mechanisms Control the (2002) (0)
- Protein and mRNA in Human Eosinophils IL-3 Induces Down-Regulation of CCR 3 Proudfoot and Jörn Elsner (2001) (0)
- Swapan Amino-Terminal Alanine-Methionine Protein 4, a Property Strongly Enhanced by -Chemokine Macrophage Inflammatory b the C-C Chemokine Receptor 3 Antagonism by (0)
- RANTES peptide fragments, and this, as well as containing compositions suitable for the treatment of inflammation (1997) (0)
- Differential Activation of CC Chemokine Receptors by (2000) (0)
- Competitive Glycosaminoglycan Binding Chemokine Cooperativity Is Caused by (2014) (0)
- A novel strategy for blocking chemokine mediated inflammation (2003) (0)
- ID: 75: Unraveling the properties required for an effective therapeutic antibody targeting a chemokine (2015) (0)
- Mediated through CCR 3 Chemokine Ligand 5 Analogues Is Not Amino-Terminally Modified RANTES / CC Inhibition of Airway Inflammation by Offord and (2003) (0)
- During Allergic Pleurisy in Mice Mediate the Recruitment of Eosinophils Production Cooperates with Eotaxin to 4 Stem Cell Factor-Induced Leukotriene B (2001) (0)
- Candida Albicans Phosphomannose Isomerase (1997) (0)
- Inhibiting the oligomerisation and glycosaminoglycan binding of the chemokine CCL5 reduces experimental liver injury in vivo (2012) (0)
- Down-regulation of CC chemokine receptor 3 protein and mRNA in human eosinophils mediated by IL-3 (2002) (0)
- Chronic Colitis in the Rat Mediator of the Progression from Acute to The Chemokine RANTES Is a Crucial (2000) (0)
- O043 Treatment with chemokine-binding protein Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke in mice (2012) (0)
- Where are we with anti-chemokine therapies? (2009) (0)
- human RANTES complexed to heparin-derived disaccharide III-S (2004) (0)
- HUMAN RANTES, NMR, 13 STRUCTURES (1996) (0)
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Amanda Elizabeth Inn Proudfoot?
Amanda Elizabeth Inn Proudfoot is affiliated with the following schools: